Newest Oldest Showing 1-2 of 2 results
Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Appropriate Use of Tocilizumab in COVID-19: Early Use is Beneficial

Lütfiye Nilsun Altunal and others

Clinically COVID-19 can be observed with mild symptoms such as fever, malaise, cough, and also severe symptoms such as acute respiratory distress syndrome (ARDS) that may require respiratory support in up to 25% of the patients . COVID-19 has a high mortality rate, in hospitalized (...) Read More

Case Report / VOLUME 2, ISSUE 1, APRIL 2020

Adverse Cardiac Events Related to Hydroxychloroquine Prophylaxis and Treatment of COVID-19

Rehile Zengin and others

Hydroxychloroquine is commonly used for the treatment of rheumatic diseases because of its antinflammatory effects. It is a 4-amino-quinoline that is widely used for the treatment purposes. The Scientific Advisory Board of Ministry of Health of Turkey for COVID-19 recommends HCQ for treatment and also for prophylactic use of COVID-19. Infectious Diseases Society of America (IDSA) suggested the HCQ but also warned Read More